• 1 January 1988
    • journal article
    • research article
    • Vol. 244  (1) , 190-194
Abstract
We have recently demonstrated the presence of A1 adenosine receptors on canine parietal cells which are involved in the inhibition of histamine-stimulated acid secretion. In order to demonstrate the importance of endogenously generated adenosine on acid secretion we examined the effect of compounds that either increase or decrease the availability of adenosine to the A1 receptor on histamine-stimulated parietal cell aminopyrine-(AP) accumulation. Inclusion of 10 .mu.M 8-phenyltheophylline, an adenosine receptor antagonist, with the cells resulted in a 35 .+-. 12% and 31 .+-. 9% increase in parietal cell AP accumulation at histamine concentrations of 1 .mu.M and 10 .mu.M, respectively. The effect of 8-phenyltheophylline was specific to histamine in that it did not affect carbachol-stimulated AP accumulation or dibutyryl cyclic AMP-stimulated AP accumulation. Inclusion of 1 .mu.M dipyridamole, an inhibitor of adenosine transport, resulted in a 34 .+-. 6% and 31 .+-. 5% decrease in parietal cell AP accumulation at histamine concentrations of 1 .mu.M and 10 .mu.M, respectively. Again the effect of dipyridamole was specific to histamine in that it did not affect either carbachol- or dibutyryl cyclic AMP-stimulated AP accumulation. The addition of adenosine deaminase, 500 mU/ml, resulted in an enhanced histamine-stimulated AP accumulation at all the histamine concentrations. The effect was specific to histamine because the enzyme had no effect on either carbachol- or dibutyryl cyclic AMP-stimulated AP uptake. Our present data suggest that endogenous adenosine generated by the gastric cells can interact with parietal cell adenosine receptors to modulate acid secretion to histamine. The exact physiologic role that adenosine has in modifying parietal cell function under acid secretory conditions needs to be defined further.